141 related articles for article (PubMed ID: 35696615)
1. Probable Miglustat-Induced Psychosis in a Child With Niemann-Pick Type C.
Koç Yekedüz M; Öncül Ü; Köse E; Eminoğlu FT
Clin Neuropharmacol; 2022 Jul-Aug 01; 45(4):107-109. PubMed ID: 35696615
[TBL] [Abstract][Full Text] [Related]
2. Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect.
Nadjar Y; Hütter-Moncada AL; Latour P; Ayrignac X; Kaphan E; Tranchant C; Cintas P; Degardin A; Goizet C; Laurencin C; Martzolff L; Tilikete C; Anheim M; Audoin B; Deramecourt V; De Gaillarbois TD; Roze E; Lamari F; Vanier MT; Héron B
Orphanet J Rare Dis; 2018 Oct; 13(1):175. PubMed ID: 30285904
[TBL] [Abstract][Full Text] [Related]
3. Complete recovery from psychosis upon miglustat treatment in a juvenile Niemann-Pick C patient.
Szakszon K; Szegedi I; Magyar A; Oláh E; Andrejkovics M; Balla P; Lengyel A; Berényi E; Balogh I
Eur J Paediatr Neurol; 2014 Jan; 18(1):75-8. PubMed ID: 24119781
[TBL] [Abstract][Full Text] [Related]
4. [Adult onset Niemann-Pick type C disease and psychosis: literature review].
Maubert A; Hanon C; Metton JP
Encephale; 2013 Oct; 39(5):315-9. PubMed ID: 23928063
[TBL] [Abstract][Full Text] [Related]
5. Initiation and discontinuation of substrate inhibitor treatment in patients with Niemann-Pick type C disease.
Pérez-Poyato MS; Gordo MM; Marfa MP
Gene; 2012 Sep; 506(1):207-10. PubMed ID: 22750297
[TBL] [Abstract][Full Text] [Related]
6. Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C.
Héron B; Valayannopoulos V; Baruteau J; Chabrol B; Ogier H; Latour P; Dobbelaere D; Eyer D; Labarthe F; Maurey H; Cuisset JM; de Villemeur TB; Sedel F; Vanier MT
Orphanet J Rare Dis; 2012 Jun; 7():36. PubMed ID: 22676771
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of miglustat in Niemann-Pick C disease: a single centre experience.
Ginocchio VM; D'Amico A; Bertini E; Ceravolo F; Dardis A; Verrigni D; Bembi B; Dionisi-Vici C; Deodato F
Mol Genet Metab; 2013 Nov; 110(3):329-35. PubMed ID: 23973268
[TBL] [Abstract][Full Text] [Related]
8. Normalisation of brain spectroscopy findings in Niemann-Pick disease type C patients treated with miglustat.
Sedel F; Chabrol B; Audoin B; Kaphan E; Tranchant C; Burzykowski T; Tourbah A; Vanier MT; Galanaud D
J Neurol; 2016 May; 263(5):927-936. PubMed ID: 26984608
[TBL] [Abstract][Full Text] [Related]
9. Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann-Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report.
Cuisset JM; Sukno S; Trauffler A; Latour P; Dobbelaere D; Michaud L; Vallée L
J Med Case Rep; 2016 Sep; 10(1):241. PubMed ID: 27599728
[TBL] [Abstract][Full Text] [Related]
10. Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann-Pick disease Type C: an international, multicenter, retrospective chart review.
Pineda M; Juríčková K; Karimzadeh P; Kolnikova M; Malinova V; Insua JL; Velten C; Kolb SA
Orphanet J Rare Dis; 2019 Jan; 14(1):32. PubMed ID: 30732631
[TBL] [Abstract][Full Text] [Related]
11. Treatment of a child diagnosed with Niemann-Pick disease type C with miglustat: a case report in Brazil.
Santos ML; Raskin S; Telles DS; Löhr A; Liberalesso PB; Vieira SC; Cordeiro ML
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S357-61. PubMed ID: 18937049
[TBL] [Abstract][Full Text] [Related]
12. Effects of miglustat on stabilization of neurological disorder in niemann-pick disease type C: Iranian pediatric case series.
Karimzadeh P; Tonekaboni SH; Ashrafi MR; Shafeghati Y; Rezayi A; Salehpour S; Ghofrani M; Taghdiri MM; Rahmanifar A; Zaman T; Aryani O; Shoar BN; Shiva F; Tavasoli A; Houshmand M
J Child Neurol; 2013 Dec; 28(12):1599-606. PubMed ID: 23143717
[TBL] [Abstract][Full Text] [Related]
13. [Niemann-Pick type C disease and psychosis: Two siblings].
Maubert A; Hanon C; Metton JP
Encephale; 2015 Jun; 41(3):238-43. PubMed ID: 25238906
[TBL] [Abstract][Full Text] [Related]
14. Miglustat in Niemann-Pick disease type C patients: a review.
Pineda M; Walterfang M; Patterson MC
Orphanet J Rare Dis; 2018 Aug; 13(1):140. PubMed ID: 30111334
[TBL] [Abstract][Full Text] [Related]
15. Early miglustat therapy in infantile Niemann-Pick disease type C.
Di Rocco M; Dardis A; Madeo A; Barone R; Fiumara A
Pediatr Neurol; 2012 Jul; 47(1):40-3. PubMed ID: 22704015
[TBL] [Abstract][Full Text] [Related]
16. Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study.
Patterson MC; Mengel E; Vanier MT; Schwierin B; Muller A; Cornelisse P; Pineda M;
Orphanet J Rare Dis; 2015 May; 10():65. PubMed ID: 26017010
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of miglustat versus symptomatic therapy of Niemann-Pick disease type C.
Gutić M; Milosavljević MN; Janković SM
Int J Clin Pharm; 2022 Dec; 44(6):1442-1453. PubMed ID: 36243834
[TBL] [Abstract][Full Text] [Related]
18. Miglustat in patients with Niemann-Pick disease Type C (NP-C): a multicenter observational retrospective cohort study.
Pineda M; Wraith JE; Mengel E; Sedel F; Hwu WL; Rohrbach M; Bembi B; Walterfang M; Korenke GC; Marquardt T; Luzy C; Giorgino R; Patterson MC
Mol Genet Metab; 2009 Nov; 98(3):243-9. PubMed ID: 19656703
[TBL] [Abstract][Full Text] [Related]
19. Effects of miglustat therapy on neurological disorder and survival in early-infantile Niemann-Pick disease type C: a national French retrospective study.
Freihuber C; Dahmani-Rabehi B; Brassier A; Broué P; Cances C; Chabrol B; Eyer D; Labarthe F; Latour P; Levade T; Pichard S; Sevin C; Vanier MT; Héron B
Orphanet J Rare Dis; 2023 Jul; 18(1):204. PubMed ID: 37480097
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry.
Patterson MC; Mengel E; Vanier MT; Moneuse P; Rosenberg D; Pineda M
Orphanet J Rare Dis; 2020 Apr; 15(1):104. PubMed ID: 32334605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
